Does body weight change how strongly psilocybin hits? What studies found

The short answer

Not in the studies that tested it. A pooled analysis of 288 adults weighing 49 to 113 kg found no link between body weight and how strong psilocybin's effects were,¹ and a study of 77 people who all received the same amount found that BMI didn't predict intensity.² People given the same amount still varied a lot, but weight didn't explain it.

What the trials found

Johns Hopkins, 288 adults. Garcia-Romeu and colleagues pooled 10 studies run from 2001 to 2018, from healthy volunteers to people with cancer or major depression.¹ Every session used a weight-adjusted amount (20 to 30 mg per 70 kg, trial-administered), so what people received rose with their weight, from 14.0 to 48.6 mg. Weight, sex, age and race were tested as predictors of mystical experience, challenging experience and rated intensity. None predicted them, in any group. A subset of 103 people who happened to receive between 23 and 27 mg (weights 54 to 94 kg) stood in for a fixed amount, and weight still made no difference. Women scored somewhat higher on challenging experience in two groups, but neither result survived correction for multiple tests. The limits: the analysis was done after the fact, most participants were healthy volunteers, and 86.4% to 89.2% of each group were white.

Imperial College London, 77 adults. Spriggs and colleagues pooled three studies in which everyone received a fixed 25 mg with psychological support: 28 healthy volunteers and 49 people with depression; 30 of the 77 were women.² BMI ranged from 16.4 to 41.3; 15 people were in the obese range and 3 were underweight. BMI didn't predict the overall intensity of the altered state (p = 0.87, Bayes factor 5.83 in favor of no effect), the mystical-type "oceanic boundlessness" scale, visual changes, emotional breakthrough, or well-being two weeks later. There was weak, anecdotal evidence of more "dread of ego dissolution" at lower BMI (p = 0.076), and follow-up models found BMI added little beyond age, sex and study. With only 3 underweight people, the study couldn't say much about the extremes.

Does weight change blood levels?

Weight could still matter if heavier people ended up with less psilocin, the active compound, in their blood. Three pharmacology studies found no sign of that.

Brown and colleagues gave 12 healthy adults three weight-based amounts (0.3, 0.45 and 0.6 mg/kg, trial-administered) about a month apart and measured psilocin for 24 hours. "Variation in psilocin clearance was not predicted by body weight," and their simulations suggested a fixed 25 mg would roughly match the exposure from 0.3 mg/kg.³ In Basel, Holze and colleagues reported that body weight "had no influence on the pharmacokinetics of LSD or psilocybin" in 28 people,⁴ and in a later fixed-amount study that it "did not influence pharmacokinetics or the response to psilocybin."⁵ A 2025 review of 12 psilocin datasets found no factor that explained the differences in blood levels between people. Sex hadn't been tested.⁶

Same amount, very different results

People given exactly the same amount reach different blood levels and report very different experiences. Weight doesn't account for the spread.

At one fixed amount, the highest individual peak was about 3 to 3.5 times the lowest.⁷⁸ In Holze 2022 the two ranges overlap: some people given the lower amount reached higher peaks than some given twice as much.⁴ The felt effects spread just as widely. At the lower amount in that study, peak "any drug effect" ratings, as fitted by the study's model, ran from 13% to 98% of the scale.⁴ Among the 103 Johns Hopkins participants who got nearly the same amount, mystical-experience scores ran from 2.7 to 100 out of 100, and intensity ratings covered the whole 0 to 4 scale.¹

What does predict the experience?

Dose first, then traits and context. Studerus and colleagues pooled 23 Zurich studies: 409 sessions with 261 healthy volunteers.⁹ Dose was "clearly the most important predictor" for all 15 outcomes. Next came absorption, a personality trait describing how deeply someone gets immersed in experiences, then emotional state before the session. Setting mattered: PET scanning was the strongest predictor of anxiety, with an effect "more than twice as high as the one of drug dose". Older volunteers reported less impaired control. Gender, education and BMI weren't significantly associated with any of the 15 measures. Even so, the best model explained only 31% of the variation in overall altered state, and "more than 80% of the variance" in anxiety went unexplained.

Outside the lab. Haijen and colleagues followed people using psychedelics on their own (654 at the start, 212 by the last survey).¹⁰ Trait absorption and a higher dose "promoted all aspects of the acute experience". Clear intentions went with mystical-type experiences, and a positive mindset and recreational intentions went with lower odds of a challenging one. The models explained 21% to 34% of the variation. People reported their dose afterward, and the authors note those reports were likely shaped by how strong the experience felt.

Sex and age. A review of 14 studies found that sex didn't reliably predict drug effects, and that older age and more psychedelic experience were linked to "generally less intense effects".¹¹

Why do calculators still ask for weight?

In our check of 36 online calculators, 23 require body weight and 2 more make it optional. The rules they apply differ (straight-line scaling from a 70 kg reference, a set percentage per 10 kg, a power curve), and none of the ones we found cites a source for its rule.

Clinical trials moved the other way. The Johns Hopkins studies scaled by weight,¹ but Imperial's 2016 depression study, the COMPASS phase 2 trial and the Usona phase 2 trial all gave fixed amounts.¹²¹³¹⁴ Garcia-Romeu and colleagues concluded that "the convenience and lower cost of administering psilocybin as a fixed dose outweigh any potential advantage of weight-adjusted dosing."¹

What these studies can't tell you. The trials gave synthetic psilocybin of known strength to screened adults, and the data are thin at the extremes of weight. With mushrooms, the bigger unknown is what's in them (see the potency data). Medicines change the response in ways weight doesn't; see the interactions reference and who should avoid psilocybin. Tolerance is covered on the tolerance calculator page.